Mentor Recieves Aprovable letter for Silicone Breast Implants

[Guest guest]

How can I say " heartsick " and describe deep the

despair I feel is? . . .

When I think of all the young women and children whose

life will be forever impacted, there's no word that

can describe the feeling.

To think that these people put profits ahead of life

itself is beyond belief!

God Help Us All!

Rogene

Note: forwarded message attached.

Clarification Mentor implants have not

been approved, yet. FDA sent Mentor a letter of intent to approve their silicone breast implants. Inamed

has not received a similar letter. http://www.fda.gov/bbs/topics/news/2005/new01213.html

We will have a letter shortly.

Mentor

Receives Approvable Notification From FDA for Its Silicone Gel-Filled Breast

Implants

SANTA BARBARA,

Calif.--(BUSINESS WIRE)--July 28, 2005--Mentor Corporation (NYSE:MNT), a

leading supplier of medical products in the United States and

internationally, today announced that it has received an " approvable

letter " from the U.S. Food and Drug Administration (FDA) for the

Company's MemoryGel silicone gel-filled breast implants. The approvable

letter stipulates a number of conditions which Mentor must

satisfy in order to receive FDA approval to market and sell silicone

gel-filled breast implants in the United States.

" We

are very encouraged by this communication from the FDA, and view this letter

as a positive sign for women and their surgeons that another option will soon

be available, " said H. Levine, President and Chief Executive

Officer of Mentor Corporation. " We thank the FDA and its Advisory Panel

for the rigorous and objective review of our data and related science. "

" For

more than a decade, choices for women seeking breast augmentation and

reconstruction have been limited, " said Mr. Levine. " If ultimately

approved by the FDA, Mentor's Memory Gel breast implants

will be a significant additional option for these women. Mentor is committed

to making these important products available to women and will continue

working with the FDA to address the approvable conditions. "

Previously,

on April 13, 2005, the FDA's General Plastic Surgery Devices

Advisory Panel recommended Mentor's MemoryGel breast implants for

approval with conditions by a vote of 7 to 2. The vote of the Advisory Panel

was based primarily upon its review of Mentor's pre-market approval (PMA)

application filed in December 2003 and on the Company's PMA amendment filed

in August 2004.

The

conditions outlined in the approvable letter are generally consistent with

the Advisory Panel's deliberations. As is typical of FDA approvable

processes, Mentor intends to engage in confidential discussions

with the FDA to address these conditions, prior to the FDA's final decision

on approval.

About

Mentor Corporation

Founded

in 1969, Mentor Corporation is a leading supplier of medical products for the

global healthcare market. The Company develops, manufactures and markets

innovative, science-based products for the aesthetics, urologic specialties

and clinical and consumer healthcare markets around the world. The Company's

website is www.mentorcorp.com.

Safe

Harbor Statement

All

statements included or incorporated by reference in this release, other than

statements or characterizations of historical fact, are forward-looking

statements. These forward-looking statements are based on our current

expectations, estimates and projections about our industry, management's

beliefs and certain assumptions made by us. Forward-looking statements can

often be identified by words or phrases such as " anticipates, "

" scheduled, " " expects, " " intends, "

" plans, " " predicts, " " believes, "

" seeks, " " estimates, " " encouraged, "

" positive sign, " " is confident, " " may, "

" will, " " should, " " would, " " would

likely, " " could, " " potential, " " in the

future, " " continue, " similar expressions, and variations or

negatives of these words. In addition, any statements that refer to

expectations, projections or other characterizations of future events or

circumstances, including any underlying assumptions, are forward-looking

statements. These forward-looking statements speak only as of the date hereof

and are based upon the information available to us at this time. Such

information is subject to change, and we will not necessarily inform you of

such changes. These statements are not guarantees of future results and are

subject to risks, uncertainties and assumptions that are difficult to

predict. Therefore, our actual results could differ materially and adversely

from those expressed in any forward-looking statement as a result of various

factors.

The

Securities and Exchange Commission filings of Mentor, including, without

limitation, its Annual Reports on Form 10-K, subsequent quarterly reports on

Form 10-Q, and recent Current Reports on Form 8-K, discuss important risk

factors that could contribute to such differences or otherwise affect its

business, results of operations and financial condition. Mentor

undertakes no obligation to revise or update publicly any forward-looking

statement for any reason.

CONTACT: Mentor Corporation R. Nicholson, 805-879-6082 (Investors) or Burson-Marsteller , 202-530-4534 (Media) SOURCE: Mentor Corporation